Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.

The effects of a combination chemotherapy (CAV-PVP) consisting of cyclophosphamide, doxorubicin, hydrochloride (dox) and vincristine (CAV) alternating with cisplatin and etoposide (PVP) on peripheral blood hematopoietic progenitor cells (PBHPs) were studied in five patients with small cell lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, E., Yamamoto, A., Takahashi, Y., Maniwa, K., Yoshida, S., Mukai, J., Takaue, Y., Ogura, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968335/
https://www.ncbi.nlm.nih.gov/pubmed/8385979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968335/
https://www.ncbi.nlm.nih.gov/pubmed/8385979

Ejemplares similares